Skip to content

Primary stability of cemented vs uncemented stems in revision total knee arthroplasty measured with RSA.

Primary stability of cemented vs uncemented stems in revision total knee arthroplasty measured with RSA.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27239
Enrollment
32
Registered
2008-05-13
Start date
2008-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

revision total knee arthroplasty

Interventions

The trial treatments are cemented or press-fit implantation of the tibial and femoral stems of the Revision total knee arthroplasty and associated hospital preoperative, per-operative and postoperativ

Sponsors

Sint Maartenskliniek, Nijmegen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient is sceduled for revision total knee arthroplasty. 2. Both cemented and press-fit placed stems are indicated. 3. Patient plans to be available for follow-up through five years post-operative. 4. Patient is in stable health and free of or treated and stabilized for cardiac, pulmonary, hematological, or other conditions that would pose excessive surgical risk. 5. Patient is willing to consent and participate in the study by signing and dating and IRB-approved consent form.

Exclusion criteria

Exclusion criteria: 1. Radiologically (or per-operatively) defined Type III bone loss according to the Anderson Orthopaedic Research Institute Bone stock Classification. 2. BMI > 35. 3. Acitve, or local infection or systemic infection. 4. Patient has physical, emotional or neurological conditions that would compromise the patient’s compliance with postoperative rehabilitation protocol follow-up (e.g.: drug or alcohol abuse, serious mental illness, or general neurological conditions such as Parkinson, Multiple Sclerosis, etc.). 5. Patient has an immunosuppressive disorder (chronic condition characterized by markedly inhibited ability to respond to antigenic stimuli). Examples of such conditions include patients who are on immunosuppressive therapy (corticosteroid hormones in large amounts, cytotoxic drugs, antilymphocytic serum or irradiation in large doses), patients with acquired immunodeficiency syndrome (AIDS) or auto-immune diseases (including inflammatory arthritis). 6. Patient has a known sensitivity to materials in the device.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the stability of the prosthesis, measured with RSA. Stability is defined as migration (mm) and rotation (degrees) of the tibia and femurcomponent in all degrees of freedom.

Secondary

MeasureTime frame
- Peri-operative data (blood loss, surgery duration) - Knee Society Score - KOOS - VAS pain and VAS satisfaction - Active and passive flexion.

Contacts

Public ContactHenriëtte Gouw, de

Sint Maartenskliniek Hengstdal 3

+31 (0)24 3659049

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)